KEAP1 and non-small cell lung carcinoma: A recent retrospective study of NSCLC patients showed that KEAP-1 was a negative prognostic marker in advanced-stage (stage IIIB–IV) tumors (HR = 1.40, 95% CI: 1.23–1.61, p< 0.001, N = 4,779) (44).